ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 89 filers reported holding ENZO BIOCHEM INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $62,000 | +100.0% | 30,133 | +147.4% | 0.01% | +66.7% |
| Q4 2020 | $31,000 | +24.0% | 12,182 | +8.8% | 0.00% | 0.0% |
| Q2 2020 | $25,000 | -84.6% | 11,194 | -76.7% | 0.00% | -66.7% |
| Q2 2019 | $162,000 | +194.5% | 48,036 | +262.9% | 0.01% | +200.0% |
| Q3 2018 | $55,000 | -3.5% | 13,237 | +28.3% | 0.00% | 0.0% |
| Q1 2018 | $57,000 | -73.1% | 10,321 | -49.1% | 0.00% | -70.0% |
| Q3 2017 | $212,000 | – | 20,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,886,771 | $10,219,000 | 13.54% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $18,323,000 | 6.51% |
| Evermore Global Advisors, LLC | 1,730,607 | $6,126,000 | 5.39% |
| VIEX Capital Advisors, LLC | 1,510,401 | $5,347,000 | 3.24% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $90,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $886,000 | 0.05% |
| CORRADO ADVISORS, LLC | 19,366 | $69,000 | 0.04% |
| Cutter & CO Brokerage, Inc. | 27,827 | $99,000 | 0.02% |
| Ergoteles LLC | 177,048 | $627,000 | 0.02% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 941,760 | $3,334,000 | 0.02% |